Dark
Streaming/Mobile
Old Site
Home
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
14:12:18 EDT Tue 21 May 2024
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR Search
SEDAR Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login to Stockwatch
News for U:BIOC from 2023-05-22 to 2024-05-21 - 11 items
News Releases
In The News
Other
CA
US
Date
Sym
Price
Type
Headline
2023-09-21 08:00
U
U:BIOC
News Release
200
Enrollment Completed in the Feasibility Phase of the FORESEE Clinical Trial with Biocept ¢ € ™s CNSide ¢ „ ¢ Assay to Evaluate Patients with Leptomeningeal Metastases
2023-09-08 08:00
U
U:BIOC
News Release
200
Biocept Signs CNSide ¢ „ ¢ Licensing Agreement with Plus Therapeutics
2023-09-05 08:00
U
U:BIOC
News Release
200
Biocept to Participate in the H.C. Wainwright Global Investment Conference
2023-08-25 08:00
U
U:BIOC
News Release
200
Biocept to Hold Business Update Conference Call on August 30, 2023
2023-08-14 16:05
U
U:BIOC
News Release
200
Biocept Reports Second Quarter 2023 Financial Results
2023-08-14 08:00
U
U:BIOC
News Release
200
Biocept ¢ € ™s CNSide ¢ „ ¢ Cerebrospinal Fluid Assay Featured in Two Oral Presentations at the 2023 SNO/ASCO CNS Cancer Conference
2023-07-13 18:15
U
U:BIOC
News Release
200
Biocept Announces the Passing of Board Chair M. Faye Wilson
2023-06-20 16:15
U
U:BIOC
News Release
200
Biocept Names Antonino Morales as President and Chief Executive Officer
2023-06-14 16:05
U
U:BIOC
News Release
200
Biocept to Present at the Maxim Group Virtual Healthcare Conference Hosted by M-Vest on June 20, 2023
2023-06-05 08:00
U
U:BIOC
News Release
200
Scientific Poster Presented at the 2023 ASCO Annual Meeting Highlights Performance of Biocept ¢ € ™s CNSide ¢ „ ¢ Versus Cytology
2023-05-24 20:39
U
U:BIOC
News Release
200
Biocept Announces Pricing of $5.0 Million Underwritten Public Offering